We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+3.8%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13B
AUM Growth
-$2.88B
(-18%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-25.66%
Top 10 Holdings %
Top 10 Hldgs %
27.65%
Holding
969
New
188
Increased
241
Reduced
265
Closed
254
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$250M |
| 2 |
JD.com
JD
|
+$200M |
| 3 |
Merck
MRK
|
+$151M |
| 4 |
Broadcom
AVGO
|
+$115M |
| 5 |
Philip Morris
PM
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$339M |
| 2 |
Meta Platforms (Facebook)
META
|
+$321M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$288M |
| 4 |
Boeing
BA
|
+$260M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$234M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Communication Services | 11.21% |
| 3 | Consumer Discretionary | 10.35% |
| 4 | Financials | 10.01% |
| 5 | Technology | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Jones Lang LaSalle
JLL
$15.1B
| $1.56M | 0.01% |
11,076
-35,779
| -76% | -$5.09M |
|
477
Guardant Health
GH
$19.5B
| $1.55M | 0.01% |
17,952
-65,713
| -79% | -$5.02M |
|
478
Xerox
XRX
$337M
| $1.55M | 0.01% |
43,700
-96,998
| -69% | -$3.24M |
|
479
J.M. Smucker
SJM
$12.6B
| $1.53M | 0.01% |
+13,303
| New | +$1.62M |
|
480
Axalta
AXTA
$7.01B
| $1.52M | 0.01% |
+51,157
| New | +$1.36M |
|
481
Molson Coors Class B
TAP
$7.68B
| $1.52M | 0.01% |
+27,149
| New | +$1.58M |
|
|
LION
482
DELISTED
Fidelity Southern Corporation
LION
| $1.52M | 0.01% |
49,068
-52,385
| -52% | -$1.53M |
|
483
First Merchants
FRME
$2.72B
| $1.5M | 0.01% |
+39,477
| New | +$1.45M |
|
484
Nektar Therapeutics
NKTR
$2.39B
| $1.49M | 0.01% |
2,792
+145
| +5% | +$72.7K |
|
485
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
| $1.49M | 0.01% |
35,379
-1,750
| -5% | -$73.6K |
|
486
HF Sinclair
DINO
$15.9B
| $1.46M | 0.01% |
31,430
-133,807
| -81% | -$5.98M |
|
|
TCP
487
DELISTED
TC Pipelines LP
TCP
| $1.45M | 0.01% |
38,400
-38,400
| -50% | -$1.4M |
|
|
EPAY
488
DELISTED
Bottomline Technologies Inc
EPAY
| $1.44M | 0.01% |
32,567
-74,134
| -69% | -$3.44M |
|
|
NUVA
489
DELISTED
NuVasive, Inc.
NUVA
| $1.43M | 0.01% |
+24,369
| New | +$1.44M |
|
490
Progressive
PGR
$124B
| $1.43M | 0.01% |
17,842
-341,842
| -95% | -$26.4M |
|
491
Toll Brothers
TOL
$14B
| $1.35M | 0.01% |
36,769
-81,810
| -69% | -$3.05M |
|
492
SS&C Technologies
SSNC
$17.8B
| $1.34M | 0.01% |
+23,182
| New | +$1.4M |
|
493
Pediatrix Medical
MD
$2.16B
| $1.31M | 0.01% |
52,053
-272,425
| -84% | -$7.32M |
|
494
Kinross Gold
KGC
$28.5B
| $1.31M | 0.01% |
337,931
-96,847
| -22% | -$326K |
|
495
Vanguard Global ex-US Real Estate ETF
VNQI
$3.46B
| $1.31M | 0.01% |
22,144
+3,445
| +18% | +$202K |
|
496
Canadian National Railway
CNI
$78.3B
| $1.29M | 0.01% |
13,940
+347
| +3% | +$31.9K |
|
497
Fox Class B
FOX
$20.7B
| $1.29M | 0.01% |
+35,123
| New | +$1.27M |
|
498
OGE Energy
OGE
$10.3B
| $1.28M | 0.01% |
30,035
-150,914
| -83% | -$6.39M |
|
|
EQC
499
DELISTED
Equity Commonwealth
EQC
| $1.27M | 0.01% |
+38,996
| New | +$1.27M |
|
500
RPC Inc
RES
$1.24B
| $1.26M | 0.01% |
175,513
-147,435
| -46% | -$1.4M |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q2 2019 Portfolio in Review
As of Q2 2019, Natixis held 969 positions worth $13B, down 18% from $15.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Natixis withdrew a net $3.34B in Q2 2019, closing 254 positions and reducing 265 holdings. Its most notable exit was Amazon, an estimated $339M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.4% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Natixis opened a new position in Pfizer worth $258M.
- Natixis's largest Q2 2019 buy was Pfizer: 6,288,612 shares worth $258M.
- Natixis added most to JD.com in Q2 2019, an estimated $200M increase.
- Natixis's biggest Q2 2019 reduction was Meta Platforms (Facebook), cutting an estimated $321M.
- Natixis fully exited Amazon in Q2 2019, selling an estimated $339M.
- Natixis's ten largest holdings make up 28% of its $13B portfolio in Q2 2019.
- Natixis opened 188 new positions and closed 254 in Q2 2019.
- Natixis's portfolio value fell 18% quarter-over-quarter to $13B.
Based on Natixis's 13F filing for Q2 2019, filed 13 Aug 2019.